Changes in the size of U937 cells fllowing exposure to new generation oxazaphosphorines

• Autorzy: Opydo-Chanek M. , Stojak M. , Mazur L. , Niemeyer U.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Acta Biologica Cracoviensia. Series Zoologia
• Rocznik: 2010
• Tom: 52
• Opis fizyczny: p.25-29,fig.,ref.

Twórcy

autor

Opydo-Chanek M.

• Department of Experimental Hematology, Jagiellonian University, R.Ingardena 6, 30-060 Cracow, Poland

autor

Stojak M.

• Department of Experimental Hematology, Jagiellonian University, R.Ingardena 6, 30-060 Cracow, Poland

autor

Mazur L.

• Department of Experimental Hematology, Jagiellonian University, R.Ingardena 6, 30-060 Cracow, Poland

autor

Niemeyer U.

• University of Bielefeld, NIOMECH, Universitatsstr. 25, 33-615 Bielefeld, Germany

Bibliografia

• ADIS INTERNATIONAL LIMITED. 2005. Glufosfamide: Beta-D-Gle- IPM, D-19575. Drug R&D 6: 49-52.
• ENGEL, J., T. KLENNER, U. NIEMEYER, G. PETER, J. POHL, M. SCHüBLER, A. SCHUPKE, A. Voss, and M. WIESSLER. 2000. Glufosfamide. Drug. Future 25: 791-794.
• LIANG, J., M. HUANG, W. DUAN, X.Q. YU, and S. ZHOU. 2007. Design of new oxazaphosphorine anticancer drugs. Curr. Pharm. Design. 13: 963-978.
• MAZUR L., M. OPYDO-CHANEK, H.D. HALICKA, Z. DARŻYNKIEWICZ, and U. NIEMEYER. 2007. Induction of programmed cell death by glufosfamide. Cancer Therapeutics: The Road Ahead. A Capri Science Conference, Capri, Italy, 52. MAZUR, L., M. STOJAK, M. OPYDO-CHANEK, and U. NIEMEYER. 2009. Mitotic catastrophe induction in U937 cells by oxazaphosphorines. Acta Biol. Cracov. Series Zoologica 51: 17-22.
• MAZUR, L., M. OPYDO-CHANEK, M. STOJAK, J. BARAN, and U. NIEMEYER. 2010. Induction of DNA breakage in U937 cells by oxazaphosphorines. Folia biol. (Kraków) 58: 15-20.
• OPYDO-CHANEKM., L. MAZUR, M. STOJAK, and U. NIEMEYER. 2010. Comparative effects of new generation oxazaphosphorines on cancer cell death. 6th Swiss Apoptosis Meeting, Bern, Switherland, 46.
• Ross, D.W. 1981a. The nature of unbalanced cell growth caused by cytotoxic agents. Virchows Archiv B Cell Pathol. Zell-Pathologie 37: 225-235.
• Ross, D.W. 1981b. Volume increase in L5222 leukaemic cells following chemotherapy: Manifestation of leukaemic cell damage. Leukemia Res. 5: 73-80.
• SEKER, H., B. BERTRAM, A. BURKLE, B. KAINA, J. POHL, H. KOEPSELL, and M. WIESSLER. 2000. Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumor therapeutic agent. Brit. J. Cancer 82: 629-634.
• ZHANG, J., Q. TIAN, S. YUNG CHAN, S. CHUEN LI, S. ZHOU, W. DUAN, and Y.Z. ZHU. 2005a. Metabolism and transport of oxazaphosphorines and the clinical implications. Drug. Metab. Rev. 37: 611-703.
• ZHANG, J., Q. TIAN, S. YUNG CHAN, W. DUAN, and S. ZHOU. 2005b. Insight into oxazaphosphorine resistance and possible approaches to its circumvention. Drug Resist. Uptate. 8: 271-297.

Uwagi

PL

Rekord w opracowaniu